Cathie Wood Just Sold $3.36M in META Stock. Here’s What She Bought Instead
On Monday, Cathie Wood’s ARK Invest sold 4,520 shares of Meta Platforms ($META) through its ARK Innovation ETF ($ARKK). Based on Meta’s closing pri...
Nurix Therapeutics Inc. (NRIX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vestal Point Capital Ryan Wilder | 8,050,000 | $195,293,000 | +24% | 4.56% |
| 2. | Deep Track Capital David Kroin | 7,736,455 | $187,686,398 | +22% | 2.73% |
| 3. | Rubric Capital Management David Rosen | 7,227,778 | $175,345,894 | +193% | 1.61% |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 4,658,556 | $113,016,569 | 0.57% | |
| 5. | Perceptive Advisors Joseph Edelman | 4,320,422 | $104,813,438 | +17% | 1.57% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.19 | 5,786 | $134,148.99 | 9,110 | 2026-10-02 | Filing | |
| $26.64 | 400 | $10,655.00 | 9,110 | 2026-09-02 | Filing | |
| $25.69 | 5,387 | $138,417.35 | 9,510 | 2026-09-02 | Filing | |
| $25.47 | 1,452 | $36,982.44 | 117,227 | 2026-09-01 | Filing | |
| $25.00 | 4,356 | $108,900.00 | 117,227 | 2026-08-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,014 | $95,172 | 0% | |
| 2. | 1,270 | $30,112 | 0% | |
| 3. | 72 | $1,707 | 0% | |
| 4. | 61 | $1,446 | 0% | |
| 5. | 36 | $854 | 0% |
News See All
Why is Alector Stock (ALEC) 60% Higher Today?
Shares in U.S. biotech firm Alector ($ALEC) surged 60% in pre-market trading today after Swiss drugmaker Roche ($RHHBY) agreed to pay up to $1.27 b...
Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value
We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Nurix Therapeutics, Inc. (NASDAQ:NRIX) is one of the best biotech stocks on this list.
10 Best Biotech Stocks to Buy According to Analysts
In this article, we will be taking a look at the 10 Best Biotech Stocks to Buy According to Analysts.
9 Stocks Winning by Double Digits
Nine stocks clocked strong double-digit gains on Thursday, bucking a lackluster performance in the broader market, thanks to stellar earnings performance and acquisition news that sparked buying appetite...
8 Best Genomics Stocks to Buy According to Analysts
In this article, we will discuss: 8 Best Genomics Stocks to Buy According to Analysts.
Nurix Therapeutics Stock (NRIX) Soars 40% After $2.3B Blood Cancer Deal with Roche
Shares in biopharmaceutical company Nurix Therapeutics ($NRIX) soared nearly 40% in pre-market trading after sealing a $2.3 billion blood cancer de...
Billionaire Joe Edelman's 10 Stock Picks with Huge Upside Potential
In this article, we discuss the Billionaire Joe Edelman's Stock Picks with Huge Upside Potential.
Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29
Nurix Therapeutics, Inc. (NASDAQ:NRIX) is one of the best low priced biotech stocks to invest in. Wells Fargo cut the price target on Nurix Therapeutics, Inc.
8 Best Low Priced Biotech Stocks to Invest In
In this article, we will look at the 8 Best Low Priced Biotech Stocks to Invest In.